Research Papers:

Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease

Antonino Tuttolomondo _, Irene Simonetta, Giovanni Duro, Rosaria Pecoraro, Salvatore Miceli, Paolo Colomba, Carmela Zizzo, Antonia Nucera, Mario Daidone, Tiziana Di Chiara, Rosario Scaglione, Vittoriano Della Corte, Francesca Corpora, Danai Voyatzis and Antonio Pinto

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:61415-61424. https://doi.org/10.18632/oncotarget.18250

Metrics: PDF 2023 views  |   HTML 3170 views  |   ?  


Antonino Tuttolomondo1, Irene Simonetta1, Giovanni Duro2, Rosaria Pecoraro1, Salvatore Miceli1, Paolo Colomba2, Carmela Zizzo2, Antonia Nucera3,4, Mario Daidone1, Tiziana Di Chiara1, Rosario Scaglione1, Vittoriano Della Corte1, Francesca Corpora1, Danai Vogiatzis1 and Antonio Pinto1

1U.O.C di Medicina Interna con Stroke Care, Dipartimento Biomedico di Medicina Interna e Specialistica (Di.Bi.M.I.S), University of Palermo, Palermo, Italy

2CNR-IBIM: Institute of Biomedicine and Molecular Immunology “A. Monroy” Palermo, Palermo, Italy

3Stroke Unit, Neurology, Saint Andrea Hospital, La Spezia, Italy

4Department of Clinical Neurological Sciences, Western University, London, Ontario, Canada

Correspondence to:

Antonino Tuttolomondo, email: [email protected]

Keywords: Anderson-Fabry disease (AFD), family, variability

Received: March 20, 2017     Accepted: April 11, 2017     Published: May 29, 2017


Background: Anderson-Fabry disease (AFD) is an inborn lysosomal enzymopathy resulting from the deficient or absent activity of the lysosomal exogalactohydrolase, α-galactosidase A. This deficiency, results in the altered metabolism of glycosphingolipids which leads to their accumulation in lysosomes, thus to cellular and vascular dysfunction. To date, numerous mutations (according to recent data more than 1000 mutations) have been reported in the GLA intronic and exonic mutations. Traditionally, clinical manifestations are more severe in affected hemizygous males than in females. Nevertheless, recent studies have described severe organ dysfunction in women.

The aim of the study: This study reports clinical, biochemical, and molecular findings of the members of three Sicilian families. The clinical history of these patients highlights a remarkable interfamilial and intrafamilial phenotypic variability which characterizes Fabry disease relative to target organs and severity of clinical manifestations.

Discussion: Our findings, in agreement with previous data, report a little genotype-phenotype correlation for the disease, suggesting that the wide phenotypic variability of Anderson-Fabry disease is not completely ascribable to different gene mutations but other factors and mechanisms seem to be involved in the pathogenesis and clinical expression of the disease. Moreover, this study emphasies the importance of pedigree analysis in the family of each proband for identifying other possibly affected relatives.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18250